*GUDID Migration to the FURLS Platform - Agency IT Modernization
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $1,500,000 to $3,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The FDA is procuring technical services to migrate the Global Unique Device Identification Database (GUDID) into the FDA Unified Registration and Listing System (FURLS) as an integrated module, consolidating establishment registration, device listing, and unique device identification into a single platform. The contractor will design, develop, test, and deploy the GUDID-FURLS integration within the fiscal year, eliminating platform redundancy, strengthening data integrity through cross-system validation, and enhancing regulatory efficiency and analytical capability for the Center for Devices and Radiological Health (CDRH). The estimated solicitation release date is July 1, 2026, with an estimated award date of January 1, 2027.
The estimated award value ranges from $1.5 million to $3 million. No set-aside applies to this requirement. Questions and inquiries should be directed to cdhracquisitions@fda.hhs.gov.
Forecast text
This proposal to support the migration of the Global Unique Device Identification Database (GUDID) into the FDA Unified Registration and Listing System (FURLS) as an integrated module, consolidating the three complementary domains of medical device regulation - establishment registration, device listing, and unique device identification - into a single, cohesive platform. GUDID currently operates as a standalone application with limited cross-system integrations and validations, contributing to data quality challenges and an artificial regulatory separation that impedes holistic oversight of the medical device ecosystem. Migrating GUDID into FURLS will eliminate platform redundancy, strengthen data integrity through cross-system validation, and deliver measurable gains in regulatory efficiency and analytical capability in support of the CDRH's review tools and performance analytics functions. This effort directly advances FDA's agency IT consolidation strategy and aligns with CDRH priorities in Regulatory Efficiency & Modernization, as well as FDA's broader commitment to Innovation and Global Leadership. Contractor services will provide the technical expertise necessary to design, develop, test, and deploy the GUDID-FURLS integration within the fiscal year, ensuring continuity of operations and minimal disruption to regulated industry.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast